Collin Perry is a study coordinator for the Study of Oxytocin in Autism to improve Reciprocal Social Behaviors (SOARS-B). His responsibilities include coordinating study activities, collection, processing and shipment of biological samples, collection of patient vitals, administering neurocognitive assessments, medication dispensation and reconciliation, data entry, and general clinic and laboratory care. He also attends various fundraising and awareness events, as well as conferences across the state of North Carolina.
Collin received his Bachelors of Science in Psychology from Western Carolina University. After graduating, Collin worked as a Psychiatric Liaison to the Emergency Department at UNC-CH, School of Medicine. In this capacity he assisted in coordinating patient stays in the psychiatric ED, liaising between other psychiatric hospitals throughout the state, as well as orienting various levels of medical providers to proper procedures and providing as needed education to enhance and maintain efficiency in a high stress, time sensitive work environment. He joined Dr. Linmarie Sikich’s research program in 2013 and has assisted in numerous research projects, both sponsored and investigator initiated.
Studies that Collin has helped coordinate include but are not limited to:
* Open label and double blind, placebo controlled efficacy and tolerability of Memantine in pediatric ASD/PDD populations.
* Double blind, placebo controlled safety and tolerability of RO5028442, in adult males with high functioning ASD.
* Double blind and open label efficacy and safety of Lurasidone in adolescents with irritability associated with ASD.
* SOARS-B - Phase II Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors.